QuantiFERON-TB Gold Plus (IGRA)

The Florida Department of Health (FDOH), specifically the Palm Beach County Laboratory, is seeking to procure specialized reagents and collection devices for Mycobacterium tuberculosis specific antigen testing using the QuantiFERON-TB Gold Plus Interferon Gamma Release Assay (IGRA) system. This single-source procurement is critical for identifying tuberculosis infections and potential outbreak clusters within Palm Beach County. The contract will support the County Health Department's Tuberculosis Program's testing efforts, utilizing automated quantitative measurement of Interferon gamma on existing laboratory instrumentation. The procurement is being conducted under Chapter 60A-1.045 Florida Administrative Code, with a contract posting date of March 12, 2025, and a final day for receipt of information on April 2, 2025. The primary objective is to maintain continuity of testing capabilities with FDA-approved reagents and collection devices specifically designed for the current laboratory equipment.

The contract appears to be exclusively available to Qiagen, LLC, as the sole manufacturer and distributor of the required testing components. No specific set-aside designations for disadvantaged enterprises are mentioned in the documentation. The procurement is limited to Qiagen's proprietary testing system, which effectively restricts competitive bidding. The total estimated contract value is $360,000.00, structured for a three-year term. The contract will cover the specialized testing reagents and collection devices necessary for the Palm Beach County Laboratory's tuberculosis testing program. The opportunity is specifically tied to Leon County's jurisdiction, with the procurement focused on maintaining the existing diagnostic capabilities of the FDOH Palm Beach County Laboratory's tuberculosis testing infrastructure.